Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe top stories
life sciences
national blog main
national top stories
roche
3
×
boston
boston blog main
boston top stories
europe blog main
genentech
novartis
san francisco top stories
avapritinib
billy dunn
biogen
biopharma
blueprint medicines
cancer
cancer drugs
capmatinib
clinical trials
deals
drug prices
drug pricing
duchenne
eli lilly
evrysdi
fda
gastrointestinal stromal tumors
gene therapy
indiana blog main
indiana top stories
ionis pharmaceuticals
licensing
life science
m&a
medullary thyroid cancer
muscular dystrophy
national
What
fda
3
×
therapy
3
×
approval
drug
medicine
roche
address
approved
approves
atrophy
betting
billion
biopharma
blueprint
cancer
carries
certain
daily
deal
designed
duchenne
evrysdi
friday
gene
genetic
green
historic
home
intended
latest
lights
liquid
medicines
muscular
new
oral
pass
patients
puts
recently
Language
unset
Current search:
roche
×
therapy
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal